Phosphorylation of FOXP3 by LCK Downregulates MMP9 Expression and Represses Cell Invasion

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Nakahira, Kumiko ^a   Morita, Akihiro ^a   Kim, Nam Soon ^b   Yanagihara, Itaru ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; PHENYLALANINE; PROTEIN KINASE LCK; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR FOXP3; TYROSINE; VASCULOTROPIN A;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; ENZYME ASSAY; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; NEOPLASM; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

AMINO ACID SEQUENCE; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; S-PHASE KINASE-ASSOCIATED PROTEINS; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885402966     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077099     Document Type: Article

References (29)

1. Lalmansingh AS, Karmakar S, Jin Y, Nagaich AK, (2012) Multiple modes of chromatin remodeling by Forkhead box proteins. Biochim Biophys Acta 1819: 707-715. doi:10.1016/j.bbagrm.2012.02.018. PubMed: 22406422.
2. Benayoun BA, Caburet S, Veitia RA, (2011) Forkhead transcription factors: key players in health and disease. Trends Genet 27: 224-232. doi:10.1016/j.tig.2011.03.003. PubMed: 21507500.
3. Hannenhalli S, Kaestner KH, (2009) The evolution of Fox genes and their role in development and disease. Nat Rev Genet 10: 233-240. doi:10.1038/ni0309-233. PubMed: 19274050.
4. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, et al. (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27: 18-20. doi:10.1038/83707. PubMed: 11137992.
5. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20-21. doi:10.1038/83713. PubMed: 11137993.
6. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. doi:10.1126/science.1079490. PubMed: 12522256.
7. Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF, (2001) Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 276: 37672-37679. doi:10.1074/jbc.M104521200. PubMed: 11483607.
8. Bettelli E, Dastrange M, Oukka M, (2005) Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 102: 5138-5143. doi:10.1073/pnas.0501675102. PubMed: 15790681.
9. Ono M, Yaguchi H, Ohkura N, Kitabayashi I, Nagamura Y, et al. (2007) Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446: 685-689. doi:10.1038/nature05673. PubMed: 17377532.
10. Zuo T, Wang L, Morrison C, Chang X, Zhang H, et al. (2007) FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 129: 1275-1286. doi:10.1016/j.cell.2007.04.034. PubMed: 17570480.
11. Zhang HY, Sun H, (2010) Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer. Cancer Lett 287: 91-97. doi:10.1016/j.canlet.2009.06.001. PubMed: 19628330.
12. Wang L, Liu R, Li W, Chen C, Katoh H, et al. (2009) Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell 16: 336-346. doi:10.1016/j.ccr.2009.08.016. PubMed: 19800578.
13. Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Grüssel S, et al. (2007) Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 67: 8344-8350. doi:10.1158/0008-5472.CAN-06-3304. PubMed: 17804750.
14. Karanikas V, Speletas M, Zamanakou M, Kalala F, Loules G, et al. (2008) Foxp3 expression in human cancer cells. J Transl Med 6: 19. doi:10.1186/1479-5876-6-19. PubMed: 18430198.
15. Zuo T, Liu R, Zhang H, Chang X, Liu Y, et al. (2007) FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest 117: 3765-3773. PubMed: 18008005.
16. McInnes N, Sadlon TJ, Brown CY, Pederson S, Beyer M, et al. (2012) FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells. Oncogene 31: 1045-1054. doi:10.1038/onc.2011.293. PubMed: 21743493.
17. Köster A, Landgraf S, Leipold A, Sachse R, Gebhart E, et al. (1991) Expression of oncogenes in human breast cancer specimens. Anticancer Res 11: 193-201. PubMed: 2018353.
18. Nakamura K, Hori T, Sato N, Sugie K, Kawakami T, et al. (1993) Redox regulation of a src family protein tyrosine kinase p56lck in T cells. Oncogene 8: 3133-3139. PubMed: 8414515.
19. Hardwick JS, Sefton BM, (1995) Activation of the Lck tyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394. Proc Natl Acad Sci U S A 92: 4527-4531. doi:10.1073/pnas.92.10.4527. PubMed: 7538674.
20. Yurchak LK, Hardwick JS, Amrein K, Pierno K, Sefton BM, (1996) Stimulation of phosphorylation of Tyr394 by hydrogen peroxide reactivates biologically inactive, non-membrane-bound forms of Lck. J Biol Chem 271: 12549-12554. doi:10.1074/jbc.271.21.12549. PubMed: 8647864.
21. Björklund M, Koivunen E, (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755: 37-69. PubMed: 15907591.
22. Chakraborty G, Rangaswami H, Jain S, Kundu GC, (2006) Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis. J Biol Chem 281: 11322-11331. doi:10.1074/jbc.M512546200. PubMed: 16474166.
23. Mahabeleshwar GH, Kundu GC, (2003) Tyrosine kinase p56lck regulates cell motility and nuclear factor κB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IκBα following hypoxia/reoxygenation. J Biol Chem 278: 52598-52612. doi:10.1074/jbc.M308941200. PubMed: 14534291.
24. Morawski PA, Mehra P, Chen C, Bhatti TR, Wells AD, (2013) Foxp3 stability is regulated by cyclin-dependent kinase 2. J Biol Chem. Epub ahead of print.
25. Iwata M, Pillai M, Ramakrishnan A, Hackman RC, Joachim Deeg H, et al. (2007) Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity. Blood 109: 85-92. doi:10.1182/blood-2006-05-020289. PubMed: 16954500.
26. Kleiner DE, Stetler-Stevenson WG, (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218: 325-329. doi:10.1006/abio.1994.1186. PubMed: 8074288.
27. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, et al. (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245. PubMed: 2438036.
28. Seavitt JR, White LS, Murphy KM, Loh DY, Perlmutter RM, et al. (1999) Expression of the p56lck Y505F mutation in CD45-deficient mice rescues thymocyte development. Mol Cell Biol 19: 4200-4208. PubMed: 10330160.
29. Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, et al. (2004) Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 6: 661-672. doi:10.1016/S1534-5807(04)00131-5. PubMed: 15130491.